Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
ALLEGRA · 2 trials · 1 indication
Bioequivalence based on Cmax.
Bioequivalence based on AUC0-t.
Bioequivalence based on AUC0-inf.
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Fexofenadine 180 mg tablets | DRUG | 1 x 180 mg |
| ALLEGRA® 180 mg tablets | DRUG | 1 x 180 mg |
Inclusion Criteria: * All volunteers selected for this study will be healthy, non-smoking men and women 18 to 55 years of age, inclusive, at the time of dosing. The volunteer's body mass index (BMI) is less that or equal to 30. * If female and : * of child bearing potential, is practicing an acc...
ALLEGRA is an investigational small molecule being developed by Teva Pharmaceutical Industries Limited (TEVA). It is currently in Phase 1 clinical trials, which are studying the drug in healthy volunteers. The trials are not focused on treating a specific disease, but rather on evaluating the drug's pharmacokinetics under fasting and non-fasting conditions.
ALLEGRA is being developed by Teva Pharmaceutical Industries Limited, a company traded on the stock exchange under the ticker symbol TEVA. The drug is currently in Phase 1 clinical development, with two completed trials in healthy volunteers.
ALLEGRA is in Phase 1 clinical development. Two Phase 1 trials have been completed, both involving healthy volunteers. The drug is investigational and has not been approved by regulatory authorities.
ALLEGRA has two completed Phase 1 clinical trials. NCT00835276 studied fexofenadine hydrochloride 180 mg tablets under fasting conditions with 60 participants. NCT00835640 studied the same tablets under non-fasting conditions with 24 participants. Both trials were conducted in the United States with healthy volunteers aged 18 years and older.
Yes, ALLEGRA is the same as fexofenadine hydrochloride. The clinical trials for ALLEGRA are specifically titled 'Fexofenadine Hydrochloride 180 mg Tablets,' indicating that the drug's active ingredient is fexofenadine hydrochloride. This is the generic name for the medication.